BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotech
BioNTech’s leadership transition was announced earlier this year, with CEO Ugur Sahin and CMO Özlem Türeci leaving to start a new mRNA company. Guido Oelkers of Swedish Orphan Biovitrum AB will take over as CEO in early 2027.
Read the full article on the original site.
Read Full Article